SCHEMBL20880313

SCHEMBL20880313

C=CC(C)(P)c1c(O)cc(NN2C(=O)C(C)=C(C)C2=O)nc1-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.34
XPO1 O14980 1/20 0.34
HDAC1 Q13547 2/20 0.32
GSTO1 P78417 1/20 0.31
COMT P21964 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21556263 1.00 ABCB1 (0.34) ABCB1XPO1HDAC1GSTO1COMT
SCHEMBL21556185 0.76 XPO1 (0.44) XPO1
SCHEMBL1592489 0.71 XPO1 (0.45) XPO1
SCHEMBL24465022 0.68 XPO1 (0.42) XPO1
SCHEMBL1592486 0.67 XPO1 (0.48) XPO1
SCHEMBL24465012 0.67 XPO1 (0.40) XPO1
SCHEMBL21556239 0.64 XPO1 (0.41) XPO1
SCHEMBL1592871 0.60 BACE1 (0.47) XPO1
SCHEMBL8131521 0.58 MAPT (0.54) XPO1
SCHEMBL8141682 0.57 CYP1A2 (0.67) XPO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088397-B1 COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER CANBAS CO LTD (JP) 2019-04-10 EP disclosed